Select β-Lactam Combinations Exhibit Synergy against Mycobacterium abscessus In Vitro
Author(s) -
Elizabeth StoryRoller,
Emily C. Maggioncalda,
Gyanu Lamichhane
Publication year - 2019
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.02613-18
Subject(s) - lactam , mycobacterium abscessus , in vitro , moxalactam , microbiology and biotechnology , biology , beta lactam , mycobacterium , antibiotics , chemistry , cephalosporin , bacteria , genetics , stereochemistry
Mycobacterium abscessus is a nontuberculous mycobacterium that causes invasive pulmonary infections in patients with structural lung disease.M. abscessus is intrinsically resistant to several classes of antibiotics, and an increasing number of strains isolated from patients exhibit resistance to most antibiotics considered for treatment of infections by this mycobacterium.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom